5 Best Stocks Under $10 Offering More Than 50% Upside

4. Verastem Inc. (NASDAQ:VSTM)

Verastem Inc. (NASDAQ:VSTM) is one of the 10 best stocks under $10 offering more than 50% upside.

On June 24, Verastem Inc. (NASDAQ:VSTM) revealed encouraging initial findings from the ongoing TARGET-D 101 Phase 1/2 trial of VS-7375. It is an experimental oral KRAS G12D inhibitor for patients with advanced KRAS G12D-mutated tumors. The results showed encouraging clinical activity and a satisfactory tolerance and safety profile within several dosage levels and tumor types. These included metastatic colorectal cancer, advanced non-small cell lung cancer, and metastatic pancreatic ductal adenocarcinoma.

According to Verastem Oncology’s President of Development, Michael Kauffman, VS-7375 showed anti-tumor effectiveness across a range of dosages and malignancies. Data also indicated positive outcomes from combination strategies and a favorable safety profile after the first treatment cycle. It also demonstrated concordance when used alongside anti-EGFR therapy and conventional chemotherapy, encouraging its development across colorectal, pancreatic and lung malignancies.

The company plans to enroll patients in three Phase 2 registration-directed trials as a follow-up to the TARGET-D 101 study, and it anticipates sharing further VS-7375 results at the end of this year.

Verastem Inc. (NASDAQ:VSTM) is a development-stage biopharmaceutical company involved in developing and commercializing drugs for the treatment of cancer. Its product candidates are Avutometinib, FAKZYNJA, Defactinib, VS-7375, CO-PACK, and AVMAPKI. The company is involved in clinical studies of RAMP 301, RAMP 205, FRAME, VS-7375-101, RAMP 203, and RAMP 201.

1281292 - 11759070 - 1